Russia’s Covid-19 vaccine, The truth?
Some media channels on Sunday (12th July) reported that Russia’s Sechenov University had completed clinical trials of a vaccine for the novel coronavirus (SARS-CoV-2), claiming it as the ‘first vaccine in the world to complete human trials for Covid-19.’
We are here to tell you that it’s not true and they misstated it.
Sputnik News was one of the media channels which stated that the clinical trials of the “world’s first coronavirus vaccine” had been completed.
Update– It will be marketed and produced as ‘Sputnik V’ after the Soviet satellite name. It is developed jointly by Gamaleya Research Institute and the Russian Defence Ministry.
It is an adenoviral-based vaccine against SARS-CoV-2, containing the SARS-CoV-2 S protein(spike protein) gene.
According to the data on clinicaltrials.gov , the vaccine candidate by Sechenov University produced by Gamaleya Research Institute of Epidemiology and Microbiology named as ‘Gam-COVID-Vac Lyo’ states the estimated study completion date to be on 15th August.
It might be possible that it has completed only the Phase I of clinical trials. Russian News Agency, states that Chief researcher Elena Smolyarchuk told TASS on Sunday that
“Clinical trials of vaccine against the novel coronavirus were completed on volunteers at Sechenov University, and the results of research proved the medication’s effectiveness.”
“The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20,” Smolyarchuk stated.
However, it should be noted that this vaccine candidate has only completed the Phase I clinical studies.
The purpose of the study was to evaluate the safety, tolerability and immunogenicity of the drug “Gam-COVID-Vac Lyo”. It is an lyophilizate (Powdered form from which solution is prepared) and injected in healthy individuals via intramuscular route.
The Phase I study was non-randomized two-stage study with the participation of healthy individuals.
Table 01, made as per data on clinicaltrials.gov
| Phase I Stages | Objective | Administration | Volunteers (People) | Time of Injection | Date |
|---|---|---|---|---|---|
| Stage 1 | Safety and tolerability assessment | Intramuscular, Single dose of Lyophilisate (Say Component I) | Total=18 people; Stage I(receive component I)- 9, Stage II(with Comp. II)-9 | Both monitored for 5 days | 18th June 2020 |
| Stage 2 | Safety and tolerability assessment | Intramuscular, Lyophilisate using prime-boost immunization (Component II) | Total=20 people; Comp. I on Day 1, Component 2 on 21st day, Follow-up on 7, 14, 28, 42 days | On 5th day after it is assessed to be safe | 23rd June 2020 |
“Throughout the inpatient observation and the follow-up period (180 days) of visits during the entire study, safety information will be collected”
Currently, Russia has 752,797 confirmed cases of Covid-19 making it the 4th most affected country by Covid-19. The others on the top countries in order are U.S. with 3,472,659 confirmed cases, Brazil with 1,966,748 confirmed cases and India with 1,003,832 confirmed cases of Covid-19 on 17th July 2020 as per WHO reports.
Conclusion:
The Vaccine is yet to complete Clinical trials, supposedly Phase II and Phase III. It is said to complete clinical trials and completion of the study by August 15, 2020.
Read More- Russia’s Sputnik V became World’s First Covid-19 Vaccine |
Donate To Address
Donate Via Wallets
Bitcoin- Ethereum
- Tether
- Cardano
- Polkadot
- Binance coin
- Litecoin
- Dogecoin
- Tron
- Vechain
Ethereum
Tether
Cardano
Polkadot
Binance coin
Litecoin
Dogecoin
Tron
Vechain
Donate Bitcoin to this address
Scan the QR code or copy the address below into your wallet to send some Bitcoin
Donate Ethereum to this address
Scan the QR code or copy the address below into your wallet to send some Ethereum
Donate Tether to this address
Scan the QR code or copy the address below into your wallet to send some Tether
Donate Cardano to this address
Scan the QR code or copy the address below into your wallet to send some Cardano
Donate Polkadot to this address
Scan the QR code or copy the address below into your wallet to send some Polkadot
Donate Binance coin to this address
Scan the QR code or copy the address below into your wallet to send some Binance coin
Donate Litecoin to this address
Scan the QR code or copy the address below into your wallet to send some Litecoin
Donate Dogecoin to this address
Scan the QR code or copy the address below into your wallet to send some Dogecoin
Donate Tron to this address
Scan the QR code or copy the address below into your wallet to send some Tron
Donate Vechain to this address
Scan the QR code or copy the address below into your wallet to send some Vechain
Please Add coin wallet address in plugin settings panel
About Author
Similar Posts
ALL YOU NEED TO KNOW ABOUT NOVEL CORONAVIRUS
In December 2019, a cluster of pneumonia cases appeared in Wuhan, Hubei Province, China but the cause was unknown. Scientists suspected something novel, this was not due to the bacteria as previously thought but a novel virus. WHAT IS CORONAVIRUS? Corona in Latin means crown. Under the electron microscope, the virus capsid or outer layer looks like a…
First Indian antibody detection kit for Coronavirus
COVID KAVACH ELISA Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV) at Pune developed the indigenous IgG ELISA test named “COVID KAVACH ELISA” for antibody detection for COVID-19 which is the first Indian antibody detection kit for Coronavirus. Covid-19 continues to spread across the globe, thus, the demand for testing kits is also increasing. India imports most of these diagnostic kits from other countries….
Zydus’s Vaccine for Covid-19 enters Phase II
India’s pharmaceutical company Zydus Cadila’s Vaccine candidate for Covid-19 named ‘ZyCoV-D’ claimed to have completed Phase I of clinical trials. According to a press release on its website dated on 5th August 2020, the company said to enter Phase II clinical trials from 6th August 2020. The Phase I of this vaccine candidate began on 15th July 2020 and was administered to healthy…
Your smartphones can detect coronavirus too, here’s how?
Scientists from the University of Utah in the U.S. developed a sensor that could be paired with a smartphone and can detect coronavirus. Massood Tabib-Azar, a professor at the University of Utah, electrical and computer engineering, has received a $200,000 National Science Foundation Rapid Response Research (RAPID) grant to develop a portable and reusable coronavirus sensor. The quarter-sized sensor could…